title: Delayed effect of nitric oxide synthase inhibition on the survival of rats after acute decompression.
abstract: OBJECTIVE
  The formation of bubbles in the blood stream together with the ensuing sickness after rapid decompression is assumed to depend on the physiological condition of the vascular system. In order to gain insight into the vascular function of nitric oxide in acute decompression sickness, the effects of the nitric oxide synthase inhibition by N(omega)-nitro-L-arginine methyl ester was studied in rats.
  
  
  METHODS
  Wistar rats under anaesthesia were exposed to hyperbaric conditions for two hours and decompressed approximately 2.5 hours after a single subcutaneous injection of N(omega)-nitro-L-arginine methyl ester. Scalar doses and different pressures were tested.
  
  
  RESULTS
  The fraction of the rats that died after decompression was greater in rats treated with N(omega)-nitro-L-arginine methyl ester at doses greater than 8 mg Kg-1 body weight compared to untreated rats.
  
  
  CONCLUSIONS
  Although we have not excluded effects of nitric oxide synthase inhibition on distribution of perfusion and therefore inert gas elimination from tissue during decompression as a factor, this result highlights a delayed benefit of nitric oxide synthase activity in preventing death in acute decompression sickness.
authors.affiliation: Department ofAnatomy and Human Physiology, University of Padua, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Bondì
authors.forename: A
authors.initials: A
authors.lastname: Cavaggioni
authors.forename: P
authors.initials: P
authors.lastname: Michieli
authors.forename: M
authors.initials: M
authors.lastname: Schiavon
authors.forename: G
authors.initials: G
authors.lastname: Travain
mesh_terms: D000818:Animals; D003664:Decompression; D003665:Decompression Sickness / Q000201:enzymology / Q000401:mortality* / Q000517:prevention & control; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D008297:Male; D019331:NG-Nitroarginine Methyl Ester / Q000008:administration & dosage / Q000494:pharmacology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors* / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar
chemical_list: D004791:Enzyme Inhibitors; D019001:Nitric Oxide Synthase; D019331:NG-Nitroarginine Methyl Ester